andrew huberman glp 1 GLP-1s: Overdosing, Side Effects & Long-Term Risks Neuroscientist Andrew Huberman believes GLP-1s

Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication

Semaglutide Swipe right to view full table Save over 70%

Initially approved to treat diabetes, glucagon-like peptide-1 (GLP-1) drugs are being heralded to address obesity and, more recently, obstructive sleep apnea (OSA).

At least a dozen large drugmakers are set to roll out copies of Novo Nordisks blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires on Friday.

Theyre winning the battle of the bulge and losing the war on wrinkles.